<DOC>
	<DOCNO>NCT00599976</DOCNO>
	<brief_summary>For patient atrial fibrillation heart failure , current treatment include AV nodal ablation biventricular pacing . Pulmonary vein isolation ( PVI ) new procedure patient population attempt restore sinus rhythm . This trial randomize control trial AVN ablation biventricular pace versus PVI atrial fibrillation patient congestive heart failure .</brief_summary>
	<brief_title>Comparison Pulmonary Vein Isolation Versus AV Nodal Ablation With Biventricular Pacing Patients With Atrial Fibrillation With Congestive Heart Failure ( PABA CHF )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients symptomatic atrial fibrillation NYHA IIIII symptom despite use antiarrhythmic medication . Ejection fraction require ≤ 40 % . Patients required heart failure regimen include betablockers aceinhibitors angiotensin receptor blocker patient spironolactone NYHA III patient . Patients require complete 6minute walk test ≥ 18 year age . Reversible cause AF heart failure ( HF ) pericarditis , hyperthyroidism , valvular heart disease tachycardiainduced cardiomyopathy . Postoperative AF , previous MAZE MAZElike surgery , previous leave atrial instrumentation Life expectancy ≤ 2 year Likely cardiac transplant within next 12 month Contraindication antiarrhythmic medication and/or anticoagulation Severe pulmonary disease Documented intraatrial thrombus Tumor abnormality preclude catheter introduction Cardiac surgery , MI PCI within past three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>